Recruiting studies: Adenosquamous Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · 3 location(s) · Avacta Life Sciences Ltd · NCT07454642 T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02133196 Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
Phase 1 · 3 location(s) · Diakonos Oncology Corporation · NCT04157127 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · 301 location(s) · National Cancer Institute (NCI) · NCT07061977 External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cer
Phase 1/Phase 2 · 4 location(s) · Jonsson Comprehensive Cancer Center · NCT06543576 E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226 Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatmen
Phase 3 · 4 location(s) · Revolution Medicines, Inc. · NCT07621718 PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Phase 3 · 37 location(s) · Institut Claudius Regaud · NCT05581121 E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972 Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Phase 2 · 1 location(s) · Uganda Cancer Institute · NCT07276360 Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcino
Phase 3 · 20 location(s) · Revolution Medicines, Inc. · NCT07491445 APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patient
Phase 2 · 454 location(s) · National Cancer Institute (NCI) · NCT04858334

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.